Achromobacter Xylosoxidans (ACHX) Infections

NCT03429283 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2019-07-24

No results posted yet for this study

Summary

Data extraction from bacteriological laboratory of Martinique University hospital to determine the frequency and the distribution of nosocomial infections due to Achromobacter xylosoxidans (ACHX), an emerging multi-resistant environmental bacteria. The specific tropical environment and climatic conditions in Martinique may favor ACHX development and the investigators suppose that this new opportunistic pathogen can represent a danger for hospitalized patients. The aim of our study is to describe the most affected population and try to identify the main environmental sources of contamination.

Conditions

  • Nosocomial Infection

Interventions

OTHER

descriptive retrospective epidemiological study

descriptive retrospective epidemiological study

Sponsors & Collaborators

  • University Hospital Center of Martinique

    lead OTHER

Principal Investigators

  • Karine SANCHEZ, Pharma D · Martinique University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-05-31
Completion
2017-06-30

Countries

  • Martinique

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03429283 on ClinicalTrials.gov